Introducing the project partners in detail : 7HC

Company Overview: 7hc

7hc is a pioneering Italian start-up specializing in revolutionizing drug development processes through advanced computational platforms. Our primary focus lies in creating a sophisticated service that supports the rational design, screening, and optimization of specific binders for protein targets. We aim to set a new standard for the design, development, and optimization of novel drugs.

Our Mission:
At 7hc, we are driven by a fundamental mission: to address the pressing need within the pharmaceutical industry and related sectors for a more efficient drug development pipeline. By harnessing state-of-the-art information technologies and cutting-edge algorithms, we seek to streamline drug design and optimization processes, ultimately delivering improved outcomes for businesses and patients alike.

Tackling Industry Challenges:
The drug development landscape presents significant challenges, including prolonged timelines and substantial resource investments. On average, it takes 12-14 years and over 1 billion euros to bring a drug to market from its discovery phase. Unfortunately, this journey is often marked by high failure rates, attributed to issues such as suboptimal pharmacokinetics, efficacy, toxicity, and commercial considerations.

Our Innovative Solution:
Recognizing the imperative for resource optimization, we offer a solution that addresses these challenges head-on. Through our advanced computational platforms, we empower a more efficient and cost-effective drug development process. By providing accurate pharmacokinetic estimates early in the development cycle, we can significantly reduce both time and costs associated with drug development.

Research and Publications:

  • Morbiducci U., Di Benedetto G., et al. “Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: the case of women with a history of gestational diabetes.” Comput Biol Med. 2011 Mar;41(3):146-53.
  • Morbiducci U., Di Benedetto G., et al. “Improved usability of the Minimal Model of insulin sensitivity based on automated approach and Genetic Algorithms for parameter estimation.” Clin Sci (Lond). 2007 Vol 112(4).

At 7hc, we are committed to driving innovation and making a meaningful impact on the future of drug development. Our dedication to excellence and cutting-edge technology positions us as leaders in our field, poised to shape the future of pharmaceutical research and development.

Scroll to Top